C3 Pill - yellow oval, 16mm
Generic Name: rucaparib
Pill with imprint C3 is Yellow, Oval and has been identified as Rubraca 300 mg. It is supplied by Clovis Oncology, Inc.
Rubraca is used in the treatment of Ovarian Cancer; Prostate Cancer and belongs to the drug class PARP inhibitors. Rubraca 300 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for C3
Rubraca
- Generic Name
- rucaparib
- Imprint
- C3
- Strength
- 300 mg
- Color
- Yellow
- Size
- 16.00 mm
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- PARP inhibitors
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Clovis Oncology, Inc.
- National Drug Code (NDC)
- 69660-0203
- Inactive Ingredients
-
microcrystalline cellulose,
sodium starch glycolate type A potato,
silicon dioxide,
magnesium stearate,
titanium dioxide,
magnesium silicate,
ferric oxide yellow
Note: Inactive ingredients may vary.
Related images for "C3"
More about Rubraca (rucaparib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: PARP inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
